695 related articles for article (PubMed ID: 27614379)
21. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
[TBL] [Abstract][Full Text] [Related]
22. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.
Kaneko H; Hoelschermann F; Seifert M; Tambor G; Okamoto M; Moeller V; Neuss M; Butter C
Heart Vessels; 2019 Feb; 34(2):360-367. PubMed ID: 30083944
[TBL] [Abstract][Full Text] [Related]
23. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.
Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214
[TBL] [Abstract][Full Text] [Related]
24. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
25. Safety outcomes of new versus old generation transcatheter aortic valves.
Finkelstein A; Rozenbaum Z; Zhitomirsky S; Halkin A; Banai S; Bazan S; Barbash I; Segev A; Guetta V; Danenberg H; Planner D; Orvin K; Assa HV; Assali A; Kornowski R; Steinvil A
Catheter Cardiovasc Interv; 2019 Jul; 94(1):E44-E53. PubMed ID: 30549227
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of self-expandable vs. balloon-expandable TAVI for severe aortic stenosis.
Tham JLM; Adams H; Paleri S; Wright C; Dimitriou J; Newcomb A; MacIsaac AI; Whitbourn RJ; Palmer SC
Acta Cardiol; 2020 Jun; 75(3):218-225. PubMed ID: 30931804
[No Abstract] [Full Text] [Related]
27. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
[TBL] [Abstract][Full Text] [Related]
28. Contemporary transcatheter aortic valve replacement with third-generation balloon-expandable versus self-expanding devices.
Rogers T; Steinvil A; Buchanan K; Alraies MC; Koifman E; Gai J; Torguson R; Okubagzi P; Ben-Dor I; Pichard A; Satler L; Waksman R
J Interv Cardiol; 2017 Aug; 30(4):356-361. PubMed ID: 28493389
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of three different new generation transcatheter aortic valve prostheses.
Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
[TBL] [Abstract][Full Text] [Related]
30. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
[TBL] [Abstract][Full Text] [Related]
31. Outcome of implantation of a second self-expanding valve for the treatment of residual significant aortic regurgitation.
Koifman E; Patel N; Weissman G; Kiramijyan S; Didier R; Torguson R; Kumar S; Tavil-Shatelyan A; Ben-Dor I; Satler LF; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2017 Oct; 90(4):673-679. PubMed ID: 28296039
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves.
Kawashima H; Wang R; Mylotte D; Jagielak D; De Marco F; Ielasi A; Onuma Y; den Heijer P; Terkelsen CJ; Wijns W; Serruys PW; Soliman O
Glob Heart; 2021 Mar; 16(1):20. PubMed ID: 33833944
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes with balloon-expandable and self-expandable prostheses in patients undergoing transfemoral transcatheter aortic valve implantation for severe aortic stenosis.
Vollenbroich R; Wenaweser P; Macht A; Stortecky S; Praz F; Rothenbühler M; Roost E; Hunziker L; Räber L; Windecker S; Pilgrim T
Int J Cardiol; 2019 Sep; 290():45-51. PubMed ID: 30971373
[TBL] [Abstract][Full Text] [Related]
34. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
[TBL] [Abstract][Full Text] [Related]
35. Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device.
Vendrik J; van Kesteren F; van Mourik MS; Piek JJ; Tijssen JG; Henriques JPS; Wykrzykowska JJ; de Winter RJ; Driessen AHG; Kaya A; Vis MM; Koch KT; Baan J
Am J Cardiol; 2018 Apr; 121(7):856-861. PubMed ID: 29415808
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of balloon- versus mechanically-expandable transcatheter heart valves considering landing zone calcification.
Schofer N; Deuschl F; Schön G; Seiffert M; Linder M; Schaefer A; Schirmer J; Lubos E; Reichenspurner H; Blankenberg S; Conradi L; Schäfer U
J Cardiol; 2018 Jun; 71(6):540-546. PubMed ID: 29548665
[TBL] [Abstract][Full Text] [Related]
37. Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis.
Harrison JK; Hughes GC; Reardon MJ; Stoler R; Grayburn P; Hebeler R; Liu D; Chang Y; Popma JJ;
JACC Cardiovasc Interv; 2017 Jan; 10(2):168-175. PubMed ID: 28104211
[TBL] [Abstract][Full Text] [Related]
38. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
Kaya D; Tanriverdi Z; Dursun H; Colluoglu T
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270
[TBL] [Abstract][Full Text] [Related]
39. Sapien 3 Transcatheter Aortic Valve Implantation With Moderate or Without Predilation.
Abramowitz Y; Jilaihawi H; Chakravarty T; Maeno Y; Kawamori H; Kazuno Y; Mangat G; Rami T; Allison Z; Anderson D; Chan L; Cheng W; Makkar RR
J Invasive Cardiol; 2016 Oct; 28(10):421-426. PubMed ID: 27705892
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
